Jeena Sikho Lifecare Limited — Important, 15-07-2025: Updates

Jeena Sikho Lifecare (JSLL) highlighted its commitment to evidence-based Ayurvedic practices with the publication of two research articles authored by its medical professionals, including the Managing Director. These studies showcase significant success in Ayurvedic management of diabetes. One case demonstrated rapid reversal in an asymptomatic patient, with HbA1c dropping from 9.8% to 5.64% in a month. Another case highlighted a substantial reduction in HbA1c from 10.4% to 4.9% and full symptom relief for uncontrolled Type 2 diabetes with neuropathy within 74 days. This strengthens the credibility and efficacy claims of JSLL's Ayurvedic treatments, a positive for investor perception.